Akero Therapeutics
(NASDAQ) AKRO
Akero Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$292.82M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AKRO News
AKRO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Akero Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
67
CEO
Andrew Cheng, MD, PhD
Website
www.akerotx.comHeadquarters
South San Francisco, CA 94080, US
AKRO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-31%
Return on Capital
-34%
Return on Assets
-29%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$285.42M
EBITDA
$247.37M
Operating Cash Flow
$230.11M
Capital Expenditure
$999.00K
Free Cash Flow
$231.11M
Cash & ST Invst.
$743.08M
Total Debt
$36.46M
Akero Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
69
N/A
Net Income
$81.57M
-12.2%
EBITDA
$80.47M
-12.6%
Quarterly Fundamentals
Net Cash
$736.66M
+8.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$289.00K
-99.2%
Short Term Debt
$875.00K
+38.7%
Return on Assets
-29.12%
N/A
Return on Invested Capital
-34.45%
N/A
Free Cash Flow
$67.17M
+4.6%
Operating Cash Flow
$67.17M
+4.6%